920966-51-4 Usage
Uses
Used in Medicinal Chemistry:
1H-Pyrrolo[2,3-b]pyridine, 3-bromo-4-chloro-1-(phenylsulfonyl)is used as a potential pharmaceutical agent for its possible biological activities, such as enzyme inhibition or receptor modulation. The presence of bromine and chlorine substituents, along with the phenylsulfonyl group, may contribute to its interaction with biological targets, making it a valuable compound for drug development.
Used in Organic Synthesis:
In the field of organic synthesis, 1H-Pyrrolo[2,3-b]pyridine, 3-bromo-4-chloro-1-(phenylsulfonyl)serves as a valuable building block for the creation of more complex organic molecules. Its unique structure and functional groups can be further modified or used as a starting material for the synthesis of novel compounds with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Research and Development:
The ongoing research into the properties and applications of 1H-Pyrrolo[2,3-b]pyridine, 3-bromo-4-chloro-1-(phenylsulfonyl)aims to explore its full potential in contributing to the development of new drugs and materials. This includes understanding its chemical reactivity, stability, and potential interactions with biological systems, as well as identifying new synthetic routes and methods to improve its accessibility and scalability for industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 920966-51-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,0,9,6 and 6 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 920966-51:
(8*9)+(7*2)+(6*0)+(5*9)+(4*6)+(3*6)+(2*5)+(1*1)=184
184 % 10 = 4
So 920966-51-4 is a valid CAS Registry Number.
InChI:InChI=1/C13H8BrClN2O2S/c14-10-8-17(13-12(10)11(15)6-7-16-13)20(18,19)9-4-2-1-3-5-9/h1-8H
920966-51-4Relevant articles and documents
PYRIDINONYL PDK1 INHIBITORS
-
Page/Page column 180, (2008/06/13)
The present invention provides pyridinonyl PDKl inhibitors and methods of treating cancer using the same.